Danaher Corporation
-
Danaher Continues M&A Streak, Buying Life Sciences Firm Abcam for $5.7B
Abcam’s acquisition comes two months after its board announced the exploration of strategic alternatives that could include the sale of the company. Danaher beat out at least 20 companies that were potential buyers of the life sciences tools and antibody development firm.
-
Debt-saddled GE sells off BioPharma business to Danaher for $21.4B
The industrial conglomerate said the move was designed to reduce its leverage and improve its balance sheet. The company carried almost $115 billion in debt during the first nine months of 2018.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.